Die folgenden Begriffe wurden einbezogen:
"Multiple Sklerose", "multiple sclerosis", 多発性硬化症
-
Int J Neurosci 84 (1-4): 177-186
-
Int J Neurosci 85 (1-2): 101-110
-
Int J Neurosci 85 (1-2): 125-129
-
Int J Neurosci 86 (1-2): 79-85
-
Int J Neurosci 87 (1-2): 1-4
-
Int J Neurosci 87 (1-2): 5-15
-
Int J Neurosci 88 (1-2): 75-82
-
Int J Neurosci 85 (1-2): 93-99
-
Int J Neurosci 85 (1-2): 79-91
-
Int J Neurosci 82 (1-2): 113-125
-
Int J Neurosci 81 (3-4): 215-224
-
Int J Neurosci 83 (1-2): 69-79
-
Int J Neurosci 83 (3-4): 187-198
-
Int J Neurosci 82 (3-4): 285-302
-
Int J Neurosci 82 (3-4): 223-242
-
Int J Neurosci 83 (1-2): 81-92
-
Int J Neurosci 83 (1-2): 45-57
-
Int J Neurosci 77 (3-4): 203-227
-
Int J Neurosci 77 (3-4): 243-259
-
1994,
Sandyk R, Derpapas K
Int J Neurosci 78 (1-2): 103-109
-
1994,
Sandyk R, Iacono RP
Int J Neurosci 78 (1-2): 53-66
-
Int J Neurosci 79 (3-4): 169-184
-
Int J Neurosci 79 (3-4): 199-212
-
Int J Neurosci 75 (1-2): 65-71
-
1994,
Sandyk R, Iacono RP
Int J Neurosci 74 (1-4): 177-189
-
Int J Neurosci 79 (1-2): 75-90
-
1993,
Sandyk R, Derpapas K
Int J Neurosci 70 (1-2): 97-105
-
1993,
Sandyk R, Iacono RP
Int J Neurosci 70 (3-4): 255-269
-
Int J Neurosci 66 (3-4): 237-250
-
2024,
Jung Y, Breitbart S, Malvea A, Bhatia A, Ibrahim GM, Gorodetsky C
World Neurosurg 183: 227-238.e5
-
2024,
Jemna N, Zdrenghea AC, Frunza G, Demea AD, Hapca GE, Grad DA, Muresanu IA, Chereches RM, Muresanu FD
Neurol Sci 45 (3): 911-940
-
Scientific Committee on Health, Environmental and Emerging Risks (SCHEER),
1-35
-
2023,
Yu C, Ruan Y, Sun X, Chen C, Shen T, Liu C, Qiu W, Lu Z, Chan SO, Wang L
J Affect Disord 331: 352-361
-
2023,
Isaković J, Šerer K, Barišić B, Mitrečić D
Front Bioeng Biotechnol 11: 1139359
-
2023,
Xia Y, Wang M, Zhu Y
Cerebellum 22 (5): 954-972
-
2022,
Wyszkowska J, Pritchard C
Int J Environ Res Public Health 19 (23): 16150
-
2022,
Lanza G, Fisicaro F, Dubbioso R, Ranieri F, Chistyakov AV, Cantone M, Pennisi M, Grasso AA, Bella R, Di Lazzaro V
Front Aging Neurosci 14: 995000
-
Turk J Phys Med Rehabil 68 (1): 1-8
-
2022,
Somaa FA, de Graaf TA, Sack AT
Front Neurol 13: 793253
-
2022,
Nielsen KJ, Carstensen O, Kærgaard A, Vestergaard JM, Biering K
PLoS One 17 (3): e0264857
-
2022,
Mooshekhian A, Sandini T, Wei Z, Van Bruggen R, Li H, Li XM, Zhang Y
Exp Ther Med 23 (3): 210
-
Front Biosci (Schol Ed) 13 (2): 181-189
-
2021,
Peña-Toledo MA, Luque E, Ruz-Caracuel I, Agüera E, Jimena I, Peña-Amaro J, Tunez I
Int J Mol Sci 22 (16): 8589
-
2021,
Dragić M, Zeljković M, Stevanović I, Adžić M, Stekić A, Mihajlović K, Grković I, Ilić N, Ilić TV, Nedeljković N, Ninković M
Brain Sci 11 (6): 736
-
2021,
Wang Z, Baharani A, Wei Z, Truong D, Bi X, Wang F, Li XM, Verge VMK, Zhang Y
Clin Exp Pharmacol Physiol 48 (8): 1090-1102
-
2021,
Choi EH, Nwakalor C, Brown NJ, Lee J, Oh MY, Yang IH
Neural Regen Res 16 (2): 214-217
-
2020,
Cassani R, Novak GS, Falk TH, Oliveira AA
J Neuroeng Rehabil 17: 147
-
2020,
Begemann MJ, Brand BA, Ćurčić-Blake B, Aleman A, Sommer IE
Psychol Med 50 (15): 2465-2486
-
2020,
Dragic M, Zeljkovic M, Stevanovic I, Ilic T, Ilic N, Nedeljkovic N, Ninkovic M
Brain Res Bull 162: 208-217
-
2020,
Pourzitaki C, Dardalas I, Poutoglidou F, Kouvelas D, Kimiskidis VK
CNS Neurol Disord Drug Targets 19 (3): 220-226